Results 161 to 170 of about 316,033 (212)

Chronic hepatitis C

Current Treatment Options in Gastroenterology, 2001
Infection with hepatitis C virus (HCV) accounts for 40% of cases of chronic liver disease in the United States and is now the most common indication for liver transplantation. Estimates suggest that 4 million people (1.8%) of the American population are or have been infected with HCV.
Tram T., Tran, Paul, Martin
openaire   +2 more sources

Update on Chronic Hepatitis C

Comprehensive Therapy, 2003
Strategies for the diagnosis and treatment of chronic hepatitis C continue to evolve. Liver biopsy is now used selectively rather than routinely, and the combination peginterferon plus ribavirin is the treatment of choice for the majority of patients.
Aijaz, Ahmed, Emmet B, Keeffe
openaire   +2 more sources

Hepatic Granulomas in Chronic Hepatitis C

Journal of Clinical Gastroenterology, 2001
[No abstract available]
Mert, A, Tabak, F, Ozaras, R, Tahan, V, Senturk, H, Ozbay, G   +5 more
openaire   +2 more sources

The Prevalence of Hepatic Granulomas in Chronic Hepatitis C

Journal of Clinical Gastroenterology, 2004
Hepatic granulomas are not usual findings in chronic hepatitis C. A few studies addressing the frequency of hepatic granulomas in chronic hepatitis C reported it as less than 10%. The presence of it has been suggested to predict a favorable response to interferon treatment.
Uraz, S, Tahan, V, Ozaras, R, Senturk, H, Tozun, N, Celikel, CA, Ozbay, G, Avsar, E, Tabak, F, Kanat, M, Mert, A   +10 more
openaire   +4 more sources

Aminoadamantanes for chronic hepatitis C

Cochrane Database of Systematic Reviews, 2012
Around 3% of the world's population (approximately 160 million people) are chronically infected with hepatitis C virus. The proportion of infected people who develop clinical symptoms varies between 5% and 40%. Combination therapy with pegylated interferon-alpha plus ribavirin eradicates the virus from the blood six months after treatment (sustained ...
Lamers, M.H., Lamers, M.H., Broekman, M., Drenth, J.P.H., Drenth, J.P.H., Gluud, C.   +5 more
openaire   +3 more sources

Management of Chronic Hepatitis C

Journal of the American Academy of Nurse Practitioners, 2001
One purpose of the Clinical Practice Guideline column is to increase the awareness of the broad availability of existing guidelines and recommendations on various health topics. The hepatitis C virus (HCV) currently accounts for 20% to 40% of acute viral hepatitis, 60% to 80% of chronic hepatitis, and 20% to 30% of cirrhosis, end‐stage liver disease ...
Mary Jo Goolsby, James Blackwell
openaire   +2 more sources

Nitazoxanide for chronic hepatitis C

Cochrane Database of Systematic Reviews, 2014
Hepatitis C infection is a disease of the liver caused by the hepatitis C virus. The estimated number of chronically infected people with hepatitis C virus worldwide is about 150 million people. Every year, another three to four million people acquire the infection. Chronic hepatitis C is a leading cause of liver-related mortality and morbidity.
Kristiana, Nikolova, Christian, Gluud, Berit, Grevstad, Janus C, Jakobsen   +3 more
openaire   +2 more sources

Chronic Hepatitis C

Southern Medical Journal, 1997
Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested.
openaire   +2 more sources

Chronic Hepatitis C in Pregnancy

Obstetrics & Gynecology, 2008
To estimate outcomes, to determine whether appropriate follow-up was performed for pregnant patients with hepatitis C virus (HCV), and to show that maternal and neonatal complications would be higher in the HCV-positive group.We compared pregnant women from a drug dependence and treatment program who were HCV antibody-positive with those who were HCV ...
Eliza M F, Berkley, Kimberly K, Leslie, Sanjeev, Arora, Clifford, Qualls, Jeffrey C, Dunkelberg   +4 more
openaire   +2 more sources

Adiponectin in chronic hepatitis C

Clinical Journal of Gastroenterology, 2013
White adipose tissue has been increasingly recognized as an important endocrine organ that secretes a number of biologically active adipokines. Adiponectin, one of the major adipokines, possesses anti-inflammatory and insulin-sensitizing properties, and its serum levels typically decline with increasing body weight.
Toru, Arano, Hayato, Nakagawa, Hitoshi, Ikeda, Kazuhiko, Koike   +3 more
openaire   +2 more sources